IMBRUVICA™ (Ibrutinib) Now Approved in the u.s. For Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy

Uncategorized February 12, 2014 at 1:58 PM 0 comments

HORSHAM, PA, February 12, 2014 – Janssen Biotech, Inc. [“Janssen”] today announced the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.[1] IMBRUVICA was first approved in November 2013 for the treatmentRead More

Cancer Research UK Launches ‘Spaceship’ Smartphone Game to Seek Cancer Cures

Cancer Research UK Launches ‘Spaceship’ Smartphone Game to Seek Cancer Cures

Uncategorized February 4, 2014 at 1:51 PM 0 comments

Cancer Research UK today unveils Play to Cure: Genes in Space – a world-first mobile phone game in which people across the globe will be able to help scientists unravel gene data to find the answers to some of cancer’s toughest questions. “Play to Cure: Genes in Space will help us findRead More